Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome. (2010)
Attributed to:
Dissecting the cause of premature replicative senescence of Werner syndrome cells using selective chemical inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ph3061842
PubMed Identifier: 27713332
Publication URI: http://europepmc.org/abstract/MED/27713332
Type: Journal Article/Review
Volume: 3
Parent Publication: Pharmaceuticals (Basel, Switzerland)
Issue: 6
ISSN: 1424-8247